You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康恩貝(600572.SH):二期項目品種硫酸阿米卡星產品已投入生產
格隆匯 09-15 20:29

格隆匯9月15日丨康恩貝(600572.SH)在半年度業績説明會上表示,金華康恩貝國際化先進製藥基地一期項目品種鹽酸吡格列酮、漢防已甲素、奧美拉唑、鹽酸坦洛新、利伐沙班產品以及阿奇黴素重排物、阿奇黴素胺、克拉黴素甲化物等中間體品種均已投入生產,一期項目將於2023年內完成整體驗收;二期項目品種硫酸阿米卡星產品已投入生產,卡那黴素、大觀黴素產品進入連續試生產階段,二期項目將於2023年底前進行大觀黴素產品GMP認證以及外銷的FDA認證申報。隨着供給側改革及環保監管的趨嚴,公司在國際市場份額及議價能力仍在逐步提升,硫酸阿米卡星、鹽酸大觀黴素、硫酸大觀黴素、阿奇黴素、克拉黴素等頗具生產與出口規模的產品,依舊具有較突出國際市場地位,預計會隨着國內外原料藥市場的回暖而實現銷售增長。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account